AZ SB1001

Requires physicians licensed in Arizona to provide written informed consent materials to patients before performing breast implant surgery, effective January 1, 2022.

Mandated consent materials must include descriptions of surgical risks, manufacturer patient information with FDA warnings, and an informed consent checklist addressing breast implant-associated anaplastic large cell lymphoma, breast implant illness, and the national breast implant registry.

Requires physicians to inform patients how to report adverse events through the FDA's MedWatch program or similar programs.

Directs the Arizona Medical Board and Arizona Board of Osteopathic Examiners to develop a standardized informed consent checklist by December 1, 2021, in consultation with licensee representatives and patient advocates.

Violations constitute unprofessional conduct subject to disciplinary action.